CVRx Inc
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased … Read more
CVRx Inc (CVRX) - Total Assets
Latest total assets as of December 2025: $104.79 Million USD
Based on the latest financial reports, CVRx Inc (CVRX) holds total assets worth $104.79 Million USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
CVRx Inc - Total Assets Trend (2019–2025)
This chart illustrates how CVRx Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
CVRx Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
CVRx Inc's total assets of $104.79 Million consist of 97.0% current assets and 3.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 72.2% |
| Accounts Receivable | $10.66 Million | 10.2% |
| Inventory | $12.21 Million | 11.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how CVRx Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CVRx Inc's current assets represent 97.0% of total assets in 2025, a decrease from 99.3% in 2019.
- Cash Position: Cash and equivalents constituted 72.2% of total assets in 2025, down from 88.4% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 11.7% of total assets.
CVRx Inc Competitors by Total Assets
Key competitors of CVRx Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
CVRx Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - CVRx Inc generates 0.54x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - CVRx Inc is currently not profitable relative to its asset base.
CVRx Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.63 | 12.06 | 5.01 |
| Quick Ratio | 6.72 | 10.94 | 4.76 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $88.33 Million | $ 119.05 Million | $ 47.84 Million |
CVRx Inc - Advanced Valuation Insights
This section examines the relationship between CVRx Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.26 |
| Latest Market Cap to Assets Ratio | 1.45 |
| Asset Growth Rate (YoY) | -21.5% |
| Total Assets | $104.79 Million |
| Market Capitalization | $151.63 Million USD |
Valuation Analysis
Above Book Valuation: The market values CVRx Inc's assets above their book value (1.45 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: CVRx Inc's assets decreased by 21.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for CVRx Inc (2019–2025)
The table below shows the annual total assets of CVRx Inc from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $104.79 Million | -21.45% |
| 2024-12-31 | $133.41 Million | +15.78% |
| 2023-12-31 | $115.23 Million | -7.77% |
| 2022-12-31 | $124.94 Million | -18.10% |
| 2021-12-31 | $152.55 Million | +135.50% |
| 2020-12-31 | $64.78 Million | +122.55% |
| 2019-12-31 | $29.11 Million | -- |